A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase

Kinneret Savitsky(Tel Aviv University), Anat Bar‐Shira(Tel Aviv University), Shlomit Gilad(Tel Aviv University), Galit Rotman(Tel Aviv University), Yael Ziv(Tel Aviv University), Lina Vanagaite(Tel Aviv University), Danilo A. Tagle(National Institutes of Health), Sara Smith(Tel Aviv University), Tamar Uziel(Tel Aviv University), Sharon Sfez(Tel Aviv University), Maya Ashkenazi(Tel Aviv University), Iris Pecker(Tel Aviv University), Moshe Frydman(Sheba Medical Center), Reli Harnik(Tel Aviv University), S R Patanjali(Yale University), Andrew D. Simmons(The University of Texas Southwestern Medical Center), Gregory A. Clines(The University of Texas Southwestern Medical Center), Adam Sartiel(Tel Aviv University), Richard A. Gatti(University of California, Los Angeles), Luciana Chessa(Sapienza University of Rome), Özden Sanal(Hacettepe University), Martin F. Lavin(QIMR Berghofer Medical Research Institute), N.G.J. Jaspers(Erasmus University Rotterdam), A. Malcolm R. Taylor(University of Birmingham), C.F. Arlett(University of Sussex), Toru Miki(National Cancer Institute), Sherman M. Weissman(Yale University), Michael Lovett(The University of Texas Southwestern Medical Center), Francis S. Collins(National Institutes of Health), Yosef Shiloh(Tel Aviv University)
Science
June 23, 1995
Cited by 2,786

Abstract

A gene, ATM, that is mutated in the autosomal recessive disorder ataxia telangiectasia (AT) was identified by positional cloning on chromosome 11q22-23. AT is characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, cancer predisposition, radiation sensitivity, and cell cycle abnormalities. The disease is genetically heterogeneous, with four complementation groups that have been suspected to represent different genes. ATM, which has a transcript of 12 kilobases, was found to be mutated in AT patients from all complementation groups, indicating that it is probably the sole gene responsible for this disorder. A partial ATM complementary DNA clone of 5.9 kilobases encoded a putative protein that is similar to several yeast and mammalian phosphatidylinositol-3' kinases that are involved in mitogenic signal transduction, meiotic recombination, and cell cycle control. The discovery of ATM should enhance understanding of AT and related syndromes and may allow the identification of AT heterozygotes, who are at increased risk of cancer.


Related Papers

No related papers found

Powered by citation graph analysis